IP Verse

Syringe

Patent No. EP3381444 (titled "Syringe") was filed by Novartis on Jan 25, 2013. The application was issued on May 19, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSApr 28, 2023ELKINGTON AND FIFE
HAMM & WITTKOPPFeb 21, 2022HAMM & WITTKOPP
HOFFMANN EITLEFeb 18, 2022HOFFMANN EITLE
KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBFeb 17, 2022KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3381444

NOVARTIS
Application Number
EP18162017A
Filing Date
Jan 25, 2013
Status
Granted And Under Opposition
Apr 16, 2021
Publication Date
May 19, 2021
External Links
Slate, Register , Google Patents